1 |
Stevens C, Walz G, Singaram C, Lipman ML, Zanker B, Muggia A, Antonioli D, Peppercorn MA, Strom TB. Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 expression in inflammatory bowel disease. Dig Dis Sci. 1992 ; 37(6) : 818-26.
DOI
ScienceOn
|
2 |
Rogler G, Andus T. Cytokines in inflammatory bowel disease. World J Surg. 1998 ; 22(4) : 382-9.
DOI
ScienceOn
|
3 |
Medzhitov R, Janeway CA Jr. "Innate immunity: impact on the adaptive immune response". Curr Opin Immunol. 1997 ; 9(1) : 4-9.
DOI
ScienceOn
|
4 |
Ogata H, Hibi T. Cytokine and anti-cytokine therapies for inflammatory bowel disease. Curr Pharm Des. 2003 ; 9(14) : 1107-13.
DOI
ScienceOn
|
5 |
Zheng P, Niu FL, Liu WZ, Shi Y, Lu LG. Anti-inflammatory mechanism of oxymatrine in dextran sulfate sodium-induced colitis of rats. World J Gastroenterol. 2005 ; 11(31) : 4912-5.
DOI
|
6 |
Ishiguro K, Ando T, Maeda O, Hasegawa M, Kadomatsu K, Ohmiya N, Niwa Y, Xavier R, Goto H. Paeonol attenuates TNBS-induced colitis by inhibiting NF-B and STAT1 transactivation. Toxicol Appl Pharmacol. 2006 ; 217(1) : 35-42.
DOI
ScienceOn
|
7 |
Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. Novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990 ; 98(3) : 694-702.
DOI
|
8 |
Hendrickson BA, Gokhale R, Cho JH. Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev. 2002 ; 15(1) : 79-94.
DOI
ScienceOn
|
9 |
Murthy SN, Cooper HS, Shim H, Shah RS, Ibrahim SA, Sedergran DJ. Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin. Dig Dis Sci. 1993 ; 38(9) : 1722-34.
DOI
ScienceOn
|
10 |
Domenech E. Inflammatory bowel disease: current therapeutic options. Digestion. 2006 ; 73(1) : 67-76.
DOI
ScienceOn
|
11 |
Papadakis KA, Targan SR. Role of cytokines in the pathogenesis of inflammatory bowel disease. Annu Rev Med. 2000 ; 51 : 289-98.
DOI
ScienceOn
|
12 |
Raddatz D, Bockemuhl M, Ramadori G. Quantitative measurement of cytokine mRNA in inflammatory bowel disease: relation to clinical and endoscopic activity and outcome. Eur J Gastroenterol Hepatol. 2005 ; 17 : 547-57
DOI
|
13 |
Ryu DS, Kim SH, Kwon JH, Lee DS. Orostachys japonicus induces apoptosis and cell cycle arrest through the mitochondria-dependent apoptotic pathway in AGS human gastric cancer cells. Int J Oncol. 2014 ; 45(1) : 459-69.
DOI
|
14 |
Jung BS, Shin MK. Dictionary of the Medical Plants. Seoul : Younglimsa. 1990 : 600-1.
|
15 |
Lee HS, Lee GS, Kim SH, Kim HK, Suk DH, Lee DS. Anti-oxidizing effect of the dichloromethane and hexane fractions from Orostachys japonicusin LPS-stimulated RAW 264.7 cells via upregulation of Nrf2 expression and activation of MAPK signaling pathway. BMB Rep. 2014 ; 47(2) : 98-103.
DOI
ScienceOn
|
16 |
Danese S, Sans M, Fiocchi C. Inflammatory bowel disease; the role of environmental factors. Autoimmun Rev. 2004 ; 3 : 394-400.
DOI
ScienceOn
|
17 |
Hendrickson BA, Gokhale R, Cho JH. Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev. 2002 ; 15 : 79-94.
DOI
ScienceOn
|
18 |
Li Y, de Haar C, Chen M, Deuring J, Gerrits MM, Smits R, Xia B, Kuipers EJ, van der Woude CJ. Disease-related expression of the IL-6/STAT3/SOCS3 signaling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis. Gut. 2010 ; 59(2) : 227-35.
DOI
ScienceOn
|
19 |
Lichtenstein GR, Rutgeerts P. Inflamm Bowel Dis. 2010 ; 16(2) : 338-46.
DOI
ScienceOn
|
20 |
Danese S, Sans M, Fiocchi C. Inflammatory bowel disease: the role of environmental factors. Autoimmun Rev. 2004 ; 3(5) : 394-400.
DOI
ScienceOn
|
21 |
Bae KH. Illustrated Book of Health for Longevity. Seoul : Kyohaksa. 2003 : 180.
|
22 |
Hyams JS. Inflammatory bowel disease. Pediatr Rev. 2000 ; 21 : 291-5.
DOI
ScienceOn
|